Frontlight ResearchEarly access
Trial site
DONAUISAR Klinikum Deggendorf
- 1running trial
- 1closed trial
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Kidney cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- GBG Forschungs GmbH1 trial
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial
Running trials
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026